‘Broad daylight dacoity’, says Supreme Court on overpricing of essential cancer drugs
India’s Supreme Court rebuked the government for failing to curb the excessive pricing of essential cancer medicines, describing the practice as a ‘broad daylight dacoity.’ The bench expressed surprise at the silence of agencies tasked with regulation, urging prompt action to protect patients from unaffordable treatment costs. The remarks were made during a hearing on a petition challenging the price hikes of several oncology drugs.